At a glance
ClinicalIndex Comparison RecordN/ACompleted· 29 enrolled
Drug / intervention
ReSTOR Toricdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluating Refractive and Visual Outcomes With the Alcon Toric ReSTOR +2.5 and +3.0 Models
In Brief
A clinical study evaluating ReSTOR Toric for Cataract. Completed, enrolled 29 participants across 1 site.
Detailed Summary
The study will evaluate visual acuity and visual function with a 'blended' ReSTOR Toric intraocular lens (IOL) implantation after cataract surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsSiV Consulting
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartOct 2018
First PostedFeb 2019
Primary CompletionNov 2019
TodayJul 2026
First PostedFeb 27, 2019
Enrollment StartOct 5, 2018
Primary CompletionNov 18, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 7.3 years ago
Interventions
ReSTOR Toricdevice
ReSTOR Toric bilateral IOL implantation